Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib in elderly CML patients failing front-line TKI
NCT02810990Phase 2Completed
- Sponsor
- GIMEMA
- Start
- Nov 2016
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bosutinib in chronic myeloid leukemia (CML), sponsored by GIMEMA. Started Nov 2016; status: completed.
02
Drugs
bosutinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02810990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810990.